Effects of a psychotherapy intervention in depressed patients with coronary artery disease

Conditions

Depressive symptoms in patients with coronary artery disease Mental and Behavioural Disorders Depression

Fangauf SV, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Söllner W, Wachter R, Weber CS, Herrmann-Lingen C, SPIRR-CAD group.

2019-05-218 citations

10.1016/j.jpsychores.2019.05.006

Somatic and sociodemographic predictors of depression outcome among depressed patients with coronary artery disease - a secondary analysis of the SPIRR-CAD study.

Vitinius F, Escherich S, Deter HC, Hellmich M, Jünger J, Petrowski K, Ladwig KH, Lambertus F, Michal M, Weber C, de Zwaan M, Herrmann-Lingen C, Ronel J, Albus C.

2019-02-049 citations

10.1186/s12888-019-2026-6

The relationship between attachment orientations and the course of depression in coronary artery disease patients: A secondary analysis of the SPIRR-CAD trial.

Söllner W, Müller MM, Albus C, Behnisch R, Beutel ME, de Zwaan M, Fritzsche K, Habermeier A, Hellmich M, Jordan J, Jünger J, Ladwig KH, Michal M, Petrowski K, Ronel J, Stein B, Weber C, Weber R, Herrmann-Lingen C.

2018-02-244 citations

10.1016/j.jpsychores.2018.02.014

A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD): Results of an Observer-Blinded, Multicenter, Randomized Trial in Depressed Patients With Coronary Artery Disease

Christoph Herrmann‐Lingen, Manfred E. Beutel, Alexandra Bosbach, Hans‐Christian Deter, Kurt Fritzsche et al. (18 authors)

Psychosomatic Medicine2016-05-1794 citations

10.1097/psy.0000000000000332

Interventions

Experimental intervention: Stepwise, manualised individual and group psychotherapy in addition to usual cardiological care. Patients randomised in the intervention group receive 3 sessions of individu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Amended as of 24/01/2011: 1. Gender: both 2. Minimum age: 18, maximum age: 75 3. Patients with any manifestation of coronary heart disease with recent (less than 3 months old) coronary angiograms and elevated questionnaire scores for depression (Hospital Anxiety and Depression Scale [HADS] depression subscale greater than or equal to 8) Initial information at time of registration: 1. Gender: both 2. Minimum age: 18, maximum age: 75 3. Patients hospitalised for any manifestation of coronary heart disease with recent (less than 3 months old) coronary angiograms and elevated questionnaire scores for depression (Hospital Anxiety and Depression Scale [HADS] depression subscale greater than or equal to 8)

Exclusion criteria

Exclusion criteria: 1. Severe heart failure or other acutely life-threatening conditions 2. Severe chronic inflammatory disease 3. Current suicidal tendency 4. Severe depressive episode or other severe mental illness

Design outcomes

Primary

Measure	Time frame
Amended as of 24/01/2011: Changes from baseline to 18 months in depressive symptoms (HADS-D) Initial information at time of registration: Changes from baseline to year 1 in depressive symptoms (HADS-D)	—

Secondary

Measure	Time frame
Amended as of 24/01/2011: The following will be monitored up to 24 months: 1. Remission of depressive disorder (Structured Clinical Interview [SCID]) at baseline and 18 months 2. Type D pattern, assessed by a self rating questionnaire (DS-14) at baseline, 1, 6, 12, 18 and 24 months 3. Health-related quality of life, evaluated by the self rating questionnaires the 36-item Short Form health survey (SF-36) and EuroQuol-5D at baseline, 6, 12, 18 and 24 months 4. Cardiovascular risk profile 5. Neuroendocrine and immunological activation 6. Coagulation 7. Heart rate variability 8. Cardiac events 9. Health care utilisation and costs Initial information at time of registration: The following will be monitored up to 24 months: 1. Remission of depressive disorder (Structured Clinical Interview [SCID]) at baseline and 12 months 2. Type D pattern, assessed by a self rating questionnaire (DS-14) at baseline, 1, 6, 12, and 24 months 3. Health-related quality of life, evaluated by the self rating questionnaires the 36-item Short Form health survey (SF-36) and EuroQuol-5D at baseline, 6, 12, and 24 months 4. Cardiovascular risk profile 5. Neuroendocrine and immunological activation 6. Coagulation 7. Heart rate variability 8. Cardiac events 9. Health care utilisation and costs	—

Measure

Time frame

Amended as of 24/01/2011: The following will be monitored up to 24 months: 1. Remission of depressive disorder (Structured Clinical Interview [SCID]) at baseline and 18 months 2. Type D pattern, assessed by a self rating questionnaire (DS-14) at baseline, 1, 6, 12, 18 and 24 months 3. Health-related quality of life, evaluated by the self rating questionnaires the 36-item Short Form health survey (SF-36) and EuroQuol-5D at baseline, 6, 12, 18 and 24 months 4. Cardiovascular risk profile 5. Neuroendocrine and immunological activation 6. Coagulation 7. Heart rate variability 8. Cardiac events 9. Health care utilisation and costs Initial information at time of registration: The following will be monitored up to 24 months: 1. Remission of depressive disorder (Structured Clinical Interview [SCID]) at baseline and 12 months 2. Type D pattern, assessed by a self rating questionnaire (DS-14) at baseline, 1, 6, 12, and 24 months 3. Health-related quality of life, evaluated by the self rating questionnaires the 36-item Short Form health survey (SF-36) and EuroQuol-5D at baseline, 6, 12, and 24 months 4. Cardiovascular risk profile 5. Neuroendocrine and immunological activation 6. Coagulation 7. Heart rate variability 8. Cardiac events 9. Health care utilisation and costs

—

Countries

Germany

Outcome results

None listed